Research lines of Osteoporosis

Reading time: 1 min

Various studies are currently being carried out with new treatments for osteoporosis, but they are all still in an experimental phase.

Studies in more advanced stages and with more promising results are those focusing on the protein related to the parathyroid hormone (PTHrP) and treatment with anti-sclerostin monoclonal antibodies. 

Treatments with PTHrP and anti-sclerostin monoclonal antibodies both have an impact on bone-forming cells (osteoblasts). 

Substantiated information by:

Núria Guañabens
Pilar Peris
Celia Saura

Published: 20 February 2018
Updated: 20 February 2018


Receive the latest updates related to this content.

Thank you for subscribing!

We have received your information. Check your inbox, in a few moments you will receive a confirmation email.

An error occurred and we were unable to send your data, please try again later.